CD33-directed Immunoconjugate drugs
1 medication in the FDA established pharmacologic class “CD33-directed Immunoconjugate”.
| Drug | Type | NDC products |
|---|---|---|
| Mylotarg gemtuzumab ozogamicin | Rx | 1 |
1 medication in the FDA established pharmacologic class “CD33-directed Immunoconjugate”.
| Drug | Type | NDC products |
|---|---|---|
| Mylotarg gemtuzumab ozogamicin | Rx | 1 |